News Headlines Article

Panel Urges F.D.A. to Revoke Approval of Drug for Breast Cancer Treatment
New York Times

An advisory committee recommended Tuesday that the Food and Drug Administration revoke approval of the drug Avastin as a treatment for breast cancer, saying the drug was not helping patients.

The 12 to 1 vote represents a stinging setback for Avastin, which is now the world’s best-selling cancer drug, with global sales of about $6 billion last year. The product has at times been hailed as a near miracle, the first medicine to work by blocking the flow of blood to tumors.